Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001835:Body Weight / Q000187:drug effects; D004298:Dopamine / Q000502:physiology*; D005971:Glutamates / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology*; D007608:Kainic Acid / Q000494:pharmacology; D008297:Male; D018377:Neurotransmitter Agents / Q000502:physiology; D051381:Rats; D013378:Substantia Nigra / Q000166:cytology / Q000187:drug effects*; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D005971:Glutamates; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid; D006220:Haloperidol; D001058:Apomorphine; D007608:Kainic Acid; D004298:Dopamine